MediSens – The European Medical Imaging Conference

Advanced Cardiac Physiology and Anatomy

Miami Cardiometabolic Summit: Practical Updates in Preventive and Clinical Cardiology

Western Thoracic Surgical Association

International Society for Minimally Invasive Cardiothoracic Surgery

Congenital Heart Surgeons Society

28th International Conference on Cardiology and Healthcare

28th International Conference on Cardiology and Healthcare

Mayo Clinic researchers have shown a link between which type of oral anticoagulant a patient takes to prevent a stroke and increased risks of kidney function decline or failure.

VitalConnect Inc. announced its fifth 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company’s existing Class 2 wearable biosensor, the VitalPatch. This clearance extends the wear duration for the VitalPatch by 25 percent from 96 hours (four days) to 120 hours (five days).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now